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Introduction
Progesterone receptors  (PR) belong to the superfami-
ly of ligand-dependent nuclear receptors [1]. They are
proteins whose biological activity is affected by hor-
mone-dependent phosphorylation [2,3]. PRs are wide-
spread in an organism. In the reproductive organ they
are found in an ovary, fallopian tube, muscle and
mucous membrane of the uterus, cervix, vagina and
nipple [4-7]. Presence of PR was also observed in
pathologies of different type, among them:
endometriosis foci [8], benign tumors such as myomas
[6,9], as well as malicious tumors like mammary [10],
ovarian [11,12] and endometrial cancers [13,14]. This
is interesting that in serous ovarian cancers, expression
of this receptor is twice as high as in the healthy ovar-
ian tissue [12].
PRs appear in two almost identical isoforms, name-
ly PR-A and PR-B. They have the same places of func-
tion activation, but completely different transcription
profiles [15,16]. PR-A mainly affects the activity of an
ovary and uterus, and slightly mammary gland. Con-
versely, PR-B does not influence ovarian response, but
it has an effect on the development of mammary gland,
especially during pregnancy [17]. 
PRs are subjected to quantitative and qualitative
changes depending especially on serum concentrations
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Abstract: At present, not much is known about progesterone receptor (PR) expression and localization in postmenopausal
women ovaries. In the ovaries of reproductive age women, PR is localized in internal theca and granulosa cells, corpus
luteum, ovary surface epithelium (OSE) and in stroma. PR expression depends on the serum concentration of progesterone,
estrogen, gonadotropin and androgen. The goal of the conducted studies was to examine PR localization and expression in
the ovaries of postmenopausal women who have not applied hormone replacement therapy so far. Also, the correlation was
examined between PR expression and localization in the ovaries, steroid and gonadotropin hormone serum concentrations,
and influence of the time from the last menstruation. The material came from 50 postmenopausal women who had their
ovaries removed due to non-neoplastic diseases. The women were divided into 3 groups (A, B, C) depending on the time
from the last menstruation. The follitropin (FSH), luteotropin (LH), estradiol (E2), testosterone (T), androstendione (A) and
dehydroepiandrosterone sulphate (DHEAS) concentrations in blood plasma were measured. Monoclonal mouse anti-human
PR antibody was used for immunohistochemical detection (examination involved 50 postmenopausal ovaries). Between par-
ticular groups, E2 serum concentrations did not differ, but FSH, LH, T, A, DHEAS serum concentrations were significantly
different. Immunohistochemical nuclear localization of PR in postmenopausal women ovaries was observed. PR expression
was similar in all three groups (A, B, C). PR expression was observed in OSE nuclei and invaginations cysts deriving from
the isolation of invaginated epithelium and metaplastic columnar epithelium and in stroma. In the ovaries of postmenopausal
women who have not applied hormone replacement therapy so far, PR was detected in all three groups. Its expression did
not depend on the time from menopause and was similar in all examined groups. FSH, LH, T, A, DHEAS serum concen-
trations did not influence PR expression.
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of LH and estradiol [6,7,15,18,19], and to smaller
degree on BMI and the levels of testosterone, andros-
tendione, DHEAS, prolactin [20,21] and progesterone
[19].
PR immunolocalization and immunoexpression in
female ovaries still arouse great interest of researchers.
This is mainly because of the diagnosis and treatment
of infertility, safety of hormone therapy in the peri-
menopausal period, as well as influence on oncogene-
sis in a nipple, endometrium and ovary. In the ovaries
of reproductive-age women, PR is observed in stromal
and surface epithelial cells, in the early stages of fol-
licular development, and in theca and granular cells
[5,7,22,23]. Its localization is also well known in cor-
pus luteum [23,24]. PR expression changes during
menstrual cycle. Progesterone through PR modifies
ovarian follicular development, inhibits FSH-induced
estradiol synthesis and creation of receptors for LH,
and as a consequence maturation of follicles. In pre-
ovulatory follicles it affects growth of a follicle and
ovulation. Besides, it controls the development, func-
tioning and regression of a corpus luteum [23,24].
The structure of a postmenopausal ovary signifi-
cantly differs from that of reproductive-age. These dif-
ferences are related to changes which concern both
medulla and cortex. The division into these two struc-
tures becomes less distinct. Cortex loses its thick-
walled character, the number of follicles reduces, and
tendency to fragmentation of corpora albicantia can be
observed. Epithelial inclusion cysts develop as a result
of invagination of the surface epithelium and metapla-
sia of cuboidal epithelium. These cysts are usually
present in ovarian stroma and surroundings of corpora
albicantia. According to literature, 90% of epithelial
ovarian carcinomas develops in such cysts or in the
ovarian surface epithelium. Changes in medulla
include fibrosis of the connective tissue, hyalinization
of blood vessels, reduced blood vessel diameter, and
altering blood vessel architecture [22,25-28].
It is known that after menopause, ovaries are not
replaced by hormonally inactive connective tissue.
They produce about 50% of circulating in blood andro-
gens, especially testosterone and androstendione, and
also estrogens, however their number is much smaller
than before menopause [29,30]. On the contrary, it has
not been examined yet, what is the dynamics of PR
distribution during this period, or how it depends on
the time from the last menstruation [30,31]. Also the
role which PRs play in an ovary after menopause is
unknown. Hence, the aim of this study was to assess
PR distribution and expression in the ovaries of post-
menopausal women depending on the lapse of time
from the last menstruation and to determine correla-
tion of PR expression with concentrations of estradiol,
testosterone, dehydroepiandrosterone, androstendione
and gonadotropin in postmenopausal women.
Materials and methods
Patients. The study involved 50 postmenopausal women whose
ovaries were removed by laparotomy because of non-neoplastic
diseases of the uterus. None of them used substitutive hormone
therapy before. The Bioethical Commission gave its consent for
this study. All cases were diagnosed at the Department of Repro-
duction and Gynecology, Pomeranian Medical University,
Szczecin. The women were divided into 3 groups depending on the
time which passed from the last menstruation. Group A (25
patients) consisted of women who had the last menstruation no
more than 5 years earlier. Group B was composed of women (15
patients) whose menopause appeared 5 to 10 years earlier. Group
C (10 patients) included patients whose last menstruation was over
10 years earlier.
Hormone measurements. ELISA method enzyme immunoassay
kit (Spi-Bio France) was used to measure concentrations of follicle
stimulating hormone (FSH), luteinizing stimulating hormone
(LH), estradiol (E2), testosterone (T), androstendione (A) and
dehydroepiandrosterone sulphate (DHEAS) in blood plasma in all
the patients.
Morphology. Ovarian tissue (both cortex and medulla) was
obtained during surgery. For morphological studies, ovaries were
fixed in Bouin`s solution and 4% formalin, and embedded in paraf-
fin. Sections were cut from the respective parts of ovaries. Mor-
phological analysis was done after hematoxylin-eosin (H+E) stain-
ing.
Immunohistochemical quantification of progesterone receptor.
The paraffin-embedded specimens fixed in 4% buffered formalin
were used for analysis of immunohistochemical expression of
progesterone receptor PR. The slides were heated in citrate buffer,
pH=9.0 for 30 min. in a water bath at 96°C. Next, the sections were
incubated for 30 min. at the room temperature in humidified cham-
ber with monoclonal mouse anti-human progesterone receptor
antibody (N 1630 Dako, Denmark). The detection of anti-PR anti-
body was performed using Dako LSAB 2 KIT/HRP. Aminoethylo-
carbazole (AEC substrate chromogen) was applied to visualize the
immunohistochemical  reaction. Finally, the sections were coun-
terstained with Mayer's hematoxylin. After each step, the sections
were rinsed with Tris-buffered saline (TBS). The control sections
were incubated with TBS instead of the primary antibody.
Statistical analysis. Statistical analysis was done by means of the
Kruskal-Wallis test. p<0.05 was accepted as the significance level.
Results
Age of the examined patients
In group A the mean age of the patients was 46.3±1.2
(M±SD), in group B it was 52.4±3.8 (M±SD), and in
group C - 58.6±2.4 (M±SD). Considerable age differ-
ences were observed between women from groups: A
and B, B and C, and A and C (p<0.05).
The levels of E2 and FSH, LH, A, T, DHEAS 
in serum of the examined patients
The mean E2 , FSH, LH, A, T, DHEAS serum concen-
trations of the examined patients are illustrated in
Table 1.
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The mean E2 serum concentrations did not signifi-
cantly differ from each other groups, but the mean
FSH and T serum concentrations significantly differ
from each other between the examined groups of
women (between groups A and B, B and C, and A and
C) and LH, A, DHEAS serum concentrations signifi-
cantly differ only between group A and C and B and C.
Morphology (H+E staining)
In the ovaries of postmenopausal women, the main
structural changes in both the cortex and medulla were
observed. In the cortex, they were: 1) the reduction of
its thickness; 2) emergence of epithelial inclusion
cysts; 3) the blurred line between medulla and cortex;
4) the increased follicle number; 5) the tendency to
fragmentation of corpora albicantia; 6) surface epithe-
lium invaginations. Changes in the medulla included:
1) fibrosis and scars in stroma; 2) architectonical
changes in blood vessels with wall hyalinization and
lumen constriction. In comparison to groups A and B,
the ovaries of group C women contained small number
of corpora albicantia located in the medullary part as
well as thinned blood vessels and few lymphatic ves-
sels and nerves. Our morphological results of the post-
menopausal woman ovary (between groups A, B and
C) have been already presented [24].
Immunohistochemical results
PR immunohistochemical localization and immunoex-
pression in the ovaries of postmenopausal women
were shown in Table 2.
In our study, immunohistochemical nuclear expres-
sion of PR was revealed in OSE, epithelial inclusion
cysts and stromal cells. Immunohistochemical nuclear
expression of PR seems to be similar in the ovaries of
women who are 5 and 10 years after menopause.
Discussion 
The obtained research results seem to be very interest-
ing. After menopause, localization of PR receptors was
observed in the ovarian stromal cells, surface epitheli-
um cells and inclusion cysts with metaplastic epitheli-
um. What is more, expression of these receptors did
not change depending on the lapse of time from
menopause. The reasons for that are not known
because in other tissues, ex. adipose tissue, immuno-
expression and immunolocalization of PR decreased in
women after their last menstruation [21]. It also is not
known why our results did not reveal any correlation
between the decreasing concentrations of T, A and
DHEAS and increasing concentrations of FSH and
LH, and PR expression in postmenopausal women.
Such correlation was reported by other authors, but
their research involved women at the reproductive age
[7]. After menopause, PR expression was stronger in
the skin of those women who had higher DHEAS con-
centration [21].
A very important thing is the change in the ovarian
structure after menopause, especially in the aspect of
emergence of epithelial inclusion cysts lined with
metaplastic epithelium. These cysts are the most com-
mon reason for ovarian cancer development [22]. The
obtained results suggest that they contain PR and its
expression does not change depending on the time
which passed from menopause. The role of this recep-
tor in postmenopausal women is not known. Undoubt-
edly, it was proved that PR immunoexpression intensi-
fies the proliferation of ductal tubular cells, and thus
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Table 1. The levels of E2, FSH, LH, A, T and DHEAS in serum of the examined patients (mean ± SD).
means ±SD; * (p<0.05)
Table 2. Immunohistochemical localization and immunoexpres-
sion of PR in the ovaries of postmenopausal women.
+++ - very strong intensity, ++ - strong intensity, + - week intensity
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Fig. 1. Immunohistochemical localization and immunoexpression of PR in the ovaries of group A postmenopausal women (examined no
more than 5 years after menopause). The expression of PR was observed in some nuclei of ovarian surface epithelium (arrows) and in
some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 2. Ovary of group C postmenopausal women (examined
more than 10 years after menopause). Immunohistochemical localization of PR in some nuclei of ovarian surface epithelium (arrows) and
in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 3. Ovary of group A postmenopausal women (exam-
ined no more than 5 years after menopause). Immunohistochemical localization of PR. Strong nuclear staining is present in columnar
epithelial cells (invaginations of ovarian surface epithelium metaplastic changes, epithelial inclusion cysts) (arrows). Nuclear expression
of PR in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400). Fig. 4. Ovary of group C postmenopausal women
(examined more than 10 years after menopause). Strong nuclear expression of PR in the epithelial inclusion cyst (arrows) and in some
stromal cells (arrowheads). Stromal cells (ST) (magnification ×200). Fig. 5. Ovary of group A postmenopausal women (examined no more
than 5 years after menopause). Strong nuclear staining is present in some stromal cells (arrowheads). Stromal cells (ST) (magnification
×400). Fig. 6. Ovary of group C postmenopausal women (examined more than 10 years after menopause). Strong nuclear staining is pres-
ent in some stromal cells (arrowheads). Stromal cells (ST) (magnification ×400).
affects mammary cancer development [4,10]. Recent-
ly, some articles have been published on the subject of
an effect which PR activation have on ovarian cancer
development. It was proven that especially PR-As
strongly influence proliferation of ovarian epithelial
cells [32-34]. These receptors are present in most cases
of serous ovarian cancers [11,12,32]. It may explain an
increase in the incidence of ovarian cancer observed in
women using progestagen hormone therapy [21]. To
sum up, on the basis of the conducted studies it can be
said that in postmenopausal women ovaries, PRs are
mainly located in ovarian stromal cells, surface epithe-
lial cells and inclusion cysts with metaplastic epitheli-
um, and expression of these receptors does not change
depending on the lapse of time from menopause. Fur-
thermore, PR expression in the ovaries of post-
menopausal women does not correlate with T, A,
DHEAS and gonadotropin concentrations in blood
serum.
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